Target intelligence / Profile preview

MicroRNA 4298 (MIR4298)

Target
MIR4298
Molecular classification
Non-coding RNA, microRNA (miRNA), RNA gene
01

Overview

MicroRNA 4298 (MIR4298) is a small, non-coding RNA gene belonging to the miRNA class. Like other microRNAs, it regulates gene expression by binding to target mRNAs, primarily resulting in translation inhibition or destabilization of the target through the RNA-induced silencing complex (RISC). miRNAs, including MIR4298, play roles in regulating many fundamental cellular processes, such as development, differentiation, proliferation, and apoptosis. Dysregulation of miRNAs has been implicated in a variety of human diseases—including cancer, with MIR4298's aberrant expression being associated specifically with acute myeloid leukemia with MLL rearrangement. The precise biological functions and disease mechanisms for MIR4298, as distinct from other miRNAs, remain incompletely characterized in current literature.

Other names
hsa-mir-4298MIR4298microRNA 4298
02

Mechanism of action

Gene silencing via base pairing with 3'UTR of target mRNAs, leading to mRNA degradation or translational suppression. Incorporated into RISC complex to mediate effects.

03

Biological functions

Post-transcriptional gene regulationmRNA destabilizationTranslational inhibitionRegulation of cell proliferationRegulation of apoptosisRegulation of differentiationCell signaling modulation
04

Disease associations

Cancer (notably acute myeloid leukemia with MLL rearrangement)Other diseases linked to altered miRNA expression, not specifically described for MIR4298 in current results
05

Safety considerations

Therapeutic modulation of miRNAs poses challenges including off-target effects, broad regulatory roles, complex redundancy, and delivery issuesNo specific safety data or unique toxicity concerns for MIR4298 itself are reported in current sources
06

Biomarkers

miRNAs are used as biomarkers in many disease areas (including cancer), but there is no established disease-specific biomarker status for MIR4298 itself from the provided data

Beyond the preview

Go deeper on MicroRNA 4298 (MIR4298).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4298 (MIR4298).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call